Cases & Deals

Publicly traded life sciences company conducts FCPA investigation of China whistleblower allegations and assessment of local government enforcement action

Clients Publicly traded life sciences company

Jones Day assisted a publicly traded life sciences company with its investigation of allegations that senior management in China helped distributors evade the company's anti-corruption controls in potential violation of the FCPA. Jones Day further advised the company regarding potential FCPA liability arising from Chinese government enforcement actions alleging violations of local anti-corruption laws.